Currently, all of CITIVA’s products are only available to registered patients in Jamaica, in accordance with their government regulations and restrictions. All listed product information is only applicable to our products formulated and available outside of the USA. As our products are licensed for sale in the US, we will update the product information accordingly. All products are formulated and made available according to specific state laws as applicable.
BT is a balanced CBD/THC (1:1) formula containing CITIVA’s proprietary cannabinoid and terpene blend.
- Vaporization Pen
- 1:1 CBD/THC Ratio
- 1.9 mg CBD/ 1.9 mg THC per dose (Vaporization)
- 10 mg CBD/10 mg THC per dose (Capsules)
Active Ingredients: CO2-Extracted CBD and THC
- Vaporization pen- Zero to 15 minutes
- Capsule- Zero to 90 minutes
Observational and anecdotal data suggests that patients taking a CBD/THC ratio formulation may experience benefits which include*:
- Relief from insomnia
- Mild to moderate analgesic effect
- Anti-emetic (reduced nausea)
- Relief from symptoms related to chemotherapy
- Decreased inflammation
- Reduction in muscle spasms